Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients

NCT04982055 ↗

Phase 4 Completed 60 enrolled Clinique Saint Pierre Ottignies

RandomizedParallel-groupOpen-labelPrevention

Summary

Objective: To compare the pharmacokinetic profiles of intravenous versus subcutaneous route of administration of LMWH for thromboprophylaxis in critically ill patients

Timeline

Start: 2015-04-08
Primary completion: 2020-12-31
Completion: 2020-12-31

Publications

De Schryver N, Serck N, Eeckhoudt S, Laterre PF, Wittebole X, Gerard L. Pharmacokinetic profiles of intravenous versus subcutaneous administration of low molecular weight heparin for thromboprophylaxis in critically ill patients: A randomized controlled trial. J Crit Care. 2022 Aug;70:154029. doi: 10.1016/j.jcrc.2022.154029. Epub 2022 Apr 2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Nadroparin Calcium	Other / unclassified	3800 iu	Intravenous

Indications

No indication recorded.